StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
MGTX

MeiraGTx Holdings plc

MGTX Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗
$11.88
-0.10 -0.83%

Key statistics

from XBRL data in SEC filings
Market cap
$1.10B
Revenue (TTM)
$79.8M
Net income (TTM)
-$121M
EPS (TTM)
$-1.48
P/E ratio
Dividend yield
Free cash flow
-$50.2M
Cash
$71.5M
Total assets
$245M
Gross margin
52-week range
$6.62 – $15.35

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Jul 7, 2026 8-K Shareholder vote results Jun 15, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 8-K Entered a material agreement Apr 24, 2026 8-K Entered a material agreement Apr 16, 2026 8-K Entered a material agreement; Terminated a material agreement; Completed an acquisition or disposition; Regulation FD disclosure; Other events Apr 16, 2026 8-K Regulation FD disclosure; Other events Apr 16, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation Mar 26, 2026 8-K Entered a material agreement Jan 2, 2026 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Entered a material agreement; Regulation FD disclosure Nov 10, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Regulation FD disclosure Jun 26, 2025 8-K Shareholder vote results Jun 17, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K Regulation FD disclosure May 9, 2025 8-K Entered a material agreement; Terminated a material agreement Apr 4, 2025 10-K Fiscal year ended 2024-12-31 Mar 13, 2025 8-K Entered a material agreement; Results of operations (earnings release); Regulation FD disclosure Mar 13, 2025 8-K Other events Dec 9, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Regulation FD disclosure; Other events Oct 15, 2024 8-K Other events Aug 13, 2024 8-K Results of operations (earnings release) Aug 12, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Shareholder vote results Jun 10, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K/A Director or officer change Apr 16, 2024 10-K Fiscal year ended 2023-12-31 Mar 15, 2024 8-K Results of operations (earnings release) Mar 14, 2024 8-K Other events Feb 13, 2024 8-K Entered a material agreement; Terminated a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Regulation FD disclosure Dec 21, 2023 10-Q Quarter ended 2023-09-30 Nov 14, 2023